| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27,0 M € | +1.4% | 26,7 M € | +1.3% | 26,3 M € | +9.0% | 24,1 M € | +55.5% | 15,5 M € | +153.4% | 6,1 M € | — | — | — | — | 2,2 M € | +167.0% | 814,5 k € | ||||||
| Gross margin | — | — | — | — | — | — | 1,5 M € | +7.3% | 1,4 M € | +6.3% | 1,3 M € | +22.7% | 1,1 M € | — | — | |||||||||
| EBITDA | 1,1 M € | +38.8% | 761,0 k € | -8.5% | 831,3 k € | -21.2% | 1,1 M € | +928.1% | -127,3 k € | -781.4% | -14,4 k € | -107.3% | 198,0 k € | +143.8% | 81,2 k € | +178.3% | -103,7 k € | +68.0% | -324,3 k € | +15.0% | -381,4 k € | +24.3% | -503,6 k € | |
| Operating profit | 662,2 k € | +182.0% | 234,8 k € | +16.3% | 202,0 k € | -35.9% | 315,3 k € | +152.8% | -596,7 k € | -561.1% | -90,3 k € | -169.5% | 129,9 k € | +268.2% | 35,3 k € | +128.4% | -124,3 k € | +63.5% | -340,9 k € | +10.9% | -382,7 k € | +24.1% | -504,1 k € | |
| Profit/loss | 471,1 k € | +1534.9% | 28,8 k € | -49.0% | 56,5 k € | -71.5% | 198,4 k € | +131.8% | -623,4 k € | -509.5% | -102,3 k € | -184.9% | 120,4 k € | +506.1% | 19,9 k € | +115.1% | -131,8 k € | +64.2% | -368,4 k € | +5.8% | -391,1 k € | +23.7% | -512,5 k € | |
| Equity | 784,2 k € | +150.5% | 313,1 k € | +10.1% | 284,3 k € | +24.8% | 227,8 k € | +136.7% | -620,6 k € | -22639.0% | 2,8 k € | -97.4% | 105,0 k € | +781.5% | -15,4 k € | +56.3% | -35,3 k € | +34.0% | -53,4 k € | -456.2% | 15,0 k € | +103.0% | -493,9 k € | |
| Total assets | 9,2 M € | -25.9% | 12,4 M € | +18.8% | 10,4 M € | -14.0% | 12,1 M € | +32.0% | 9,2 M € | +313.3% | 2,2 M € | +6.9% | 2,1 M € | +51.0% | 1,4 M € | +17.1% | 1,2 M € | +27.6% | 923,0 k € | +8.7% | 849,1 k € | +125.4% | 376,7 k € | |
| Cash | 1,3 M € | +14.6% | 1,2 M € | +53.4% | 758,9 k € | -55.0% | 1,7 M € | +149.6% | 675,3 k € | +50.1% | 449,8 k € | +302.2% | 111,9 k € | +261.5% | 30,9 k € | -33.2% | 46,3 k € | +276.2% | 12,3 k € | -93.7% | 194,3 k € | +819.0% | 21,1 k € | |
| Debts | 8,4 M € | -30.5% | 12,1 M € | +19.0% | 10,2 M € | -14.8% | 11,9 M € | +21.4% | 9,8 M € | +359.3% | 2,1 M € | +9.7% | 1,9 M € | +45.6% | 1,3 M € | +17.3% | 1,1 M € | +21.0% | 942,4 k € | +13.0% | 834,1 k € | -4.2% | 870,6 k € | |
| Staff | 131,8 | 136,3 | 130,8 | 118,8 | 82 | 23,3 | 23,6 | 22,2 | 27,9 | 32,1 | 26,3 | 9,6 | ||||||||||||
Private limited company · Aalst · incorporated on 04/11/2013 · 131,8 ETP
Private limited company profitable and well capitalised. Cash position rising (+14.6%).
Solid counterparty for a standard engagement.
Eurotranspharma Belgium is a Private limited company incorporated in 2013. Its main activity is: Freight transport by road. Its registered office is in Aalst. It employs on average 131,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette